PI3K ABCam 2015

Prof Shiloh talks to ecancertv at the PI3K-Like Protein Kinases meeting about how the DNA damage response is related to cellular homeostasis.

Prof Jackson talks to ecancertv at the PI3K-Like Protein Kinases meeting about how genome instability can be exploited for cancer therapy.

Dr Lees-Miller talks to ecancertv at the PI3K-Like Protein Kinases meeting about the DNA-dependent protein kinase, DNA-PK.

Dr Gasser talks to ecancertv at the PI3K-Like Protein Kinases meeting about the impact of TOR on nuclear dynamics.

Dr Fruman talks to ecancertv at the PI3K-Like Protein Kinases meeting about the role of the PI3K and TOR pathways in cancer.

Prof Bartek talks to ecancertv at the PI3K-Like Protein Kinases meeting about how the checkpoint machinery protects against cancer.

Prof Haber talks to ecancertv at the PI3K-Like Protein Kinases meeting about how recombination can drive tumourogenesis.

Prof Foiani talks to ecancertv at the PI3K-Like Protein Kinases meeting about the rationale behind this meeting and the connections between DNA-PK, ATM, ATR and mTOR dependent pathways. In particular the links between the DNA damage response, metabolism and mechano-transduction.

Dr Hall talks to ecancertv at the PI3K-Like Protein Kinases meeting about the potential of TOR inhibition for cancer therapy.

Dr Lindqvist talks to ecancertv at the PI3K-Like Protein Kinases meeting about how mathematical modelling can be used in cancer therapy.